share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  07/23 16:22
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company, with an aggregate market value of $97,040.46, on 07/23/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Blake's compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $688,144.26.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company, with an aggregate market value of $97,040.46, on 07/23/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Blake's compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $688,144.26.
Recursion Pharmaceuticals, Inc.董事Borgeson Blake將在2024年07月23日出售公司的11,447股A類股,市值合計爲$97,040.46。這些股份最初是作爲創始人股份在2016年09月01日獲得的,並且是Blake從發行人那裏獲得的補償。這次計劃的出售是在過去三個月的一系列交易之後,總共出售了77,289股,總收入爲$688,144.26。
Recursion Pharmaceuticals, Inc.董事Borgeson Blake將在2024年07月23日出售公司的11,447股A類股,市值合計爲$97,040.46。這些股份最初是作爲創始人股份在2016年09月01日獲得的,並且是Blake從發行人那裏獲得的補償。這次計劃的出售是在過去三個月的一系列交易之後,總共出售了77,289股,總收入爲$688,144.26。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息